3 Houston innovators to know this week

Who's who

This week's Houston innovators to know includes Juliana Garaizar of Greentown Labs, Derek Armstrong of Armstrong Innovations, and Megan Siliainoff of Med Meg Creative Services. Courtesy photos

It's a new month and Houston's innovation ecosystem is continuing to grow amid the coronavirus pandemic. This week's Houston innovators to know roundup reflects that growth with a new-to-town incubator's newly names leader — plus an entrepreneur creating an virtual reality app to escape and a communications expert's advice on navigating COVID-19.

Juliana Garaizar, launch director of Greentown Houston

Juliana Garaizar is working to help set up Houston's Greentown Labs incubator with diversity and inclusion in mind. Courtesy photo

Juliana Garaizar has had to keep a huge secret for a while. The launch director of new-to-Houston Greentown Labs has known about the cleantech incubator's plan to expand to the Bayou City for a while, and now the news is out. Of course, launching amid a pandemic isn't ideal, but Garaizar says its allowed a strong relationship with the original group based in Boston to form.

"I think the silver lining of this COVID-19 experience is that we are much more integrated with the Boston team, and we're learning at a much faster rate," she says. "That's why we decided to also open Houston for virtual memberships before we open our building in Q1 of 2021."

Garaizar joined the Houston Innovators Podcast last week to share her experience with the organization and how she'll be setting up Houston operations with diversity and inclusion in mind. Read more and stream the episode.

Derek Armstrong, CEO and founder of Armstrong Innovations

Derek Armstrong, a Houston native, founded his design company, Armstrong Innovations. Photo courtesy of Oculus Go

Derek Armstrong had been working on a new virtual reality app for relaxation and meditation that users can enter into for an opportunity to escape reality for a bit — little did he know that was something more people than ever would want to do.

His company, a Houston-area industrial design startup, Armstrong Innovations, just launched two Oculus Go app games, aptly named 'Escape'. The VR app was designed with relaxation and meditation in mind but has doubled as a new way to relax and sightsee without leaving your home during the COVID-19 pandemic.

"The sights and sounds of our new app assist with mindfulness and meditation," says CEO and founder Derek Armstrong. "It's about focusing on the sights and sounds, especially with the virus growing. It's a quick getaway without having to physically go anywhere." Read more.

Megan Silianoff, founder and creative director of Mad Meg Creative Services

Megan Silianoff has been helping clients navigate communications during a pandemic. Courtesy photo

The worst part of contracting COVID-19 — aside from suffering from the disease itself — is diligently communicating the risk of exposure to people you've been around especially to coworkers, employees, clients, etc. In a guest article for InnovationMap, Megan Silianoff of Mad Meg Creative Services, sets the scene for you to be prepared should you find yourself in this situation,

"We understand as communication experts, informing a client, boss, or anyone that you've potentially exposed them is scary messaging to share," she writes. "Guilt is the number one emotion people report experiencing when they realize they've potentially exposed someone or a group of people, even though the respective exposure was inadvertent. Nevertheless it's crucial to communicate the exposure quickly and effectively as that's how Houston can hinder the spread of this disease through our city." Read more.

It's important to craft an informative and considerate message when sharing news of a COVID-19 exposure. Getty Images

4 COVID-19 messaging tips from Houston communications expert

guest column

Houston is undoubtedly hitting critical mass with COVID-19. The common sentiment has transitioned from "knowing someone who knows someone that has COVID-19" to more frequent first-hand, anecdotal experiences. When a potential exposure happens in the workplace it's vital that employees and companies alike quickly, professionally, and responsibly inform any parties that could have been indirectly exposed including vendors, clients, or meeting participants of any kind.

We understand as communication experts, informing a client, boss, or anyone that you've potentially exposed them is scary messaging to share. Guilt is the number one emotion people report experiencing when they realize they've potentially exposed someone or a group of people, even though the respective exposure was inadvertent. Nevertheless it's crucial to communicate the exposure quickly and effectively as that's how Houston can hinder the spread of this disease through our city.

So, how have we been counseling our clients as these potential exposures arise? Here are some notes and even an email template that Houstonians can use to help get them started.

Respond quickly

This is not a time to wait for certainty. Do not wait for tangible test results or any type of certitude (such as you experiencing symptoms first-hand) before notifying a person or company that you've potentially exposed them. Remember: you aren't telling someone you gave them COVID-19, you are simply telling them that you have been exposed and therefore inadvertently exposed them.

Be honest and forthcoming with information

This is not a time to offload or dwell on your feelings of guilt, albeit that's a natural emotion. A simple apology for the situation you collectively find yourself is appropriate but a deep into your own feelings and context for the situation is neither necessary nor helpful. Remember, during times of crisis, people don't remember what you said, but that you said something at all when it would have been easier not to and that you're someone of high morals and character.

Be detailed, but not too detailed

Again, you want to share concrete information versus your own personal emotions and feelings surrounding the incident. Pertinent information includes the following;

  • When and where you were exposed
  • When and where you exposed others
  • If you're currently experiencing any COVID-19 symptoms
  • Pertinent test results (if any) in regards to how you were exposed

Work from a template

Salutation:


It has come to my attention on date that I was exposed to COVID-19 through home, work, office, etc.

Because of this, it's a possibility that I unknowingly exposed you at date and place of interaction.

Though I am not currently not experiencing any symptoms and feel healthy, I wanted to let you know about this and err on the side of caution.*OR*I currently am experiencing symptoms of Covid-19 including X,Y, Z. I plan to get tested and can let you know the results when I receive them.

I apologize for this situation and am here to answer any further questions that might help you determine how to proceed accordingly.

Sincerely,
Name

------

Megan Silianoff is the founder and creative director of Mad Meg Creative Services, a Houston-based firm specializing in public relations, social media management, web design, and branding.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.


Houston researchers make headway on affordable, sustainable sodium-ion battery

Energy Solutions

A new study by researchers from Rice University’s Department of Materials Science and NanoEngineering, Baylor University and the Indian Institute of Science Education and Research Thiruvananthapuram has introduced a solution that could help develop more affordable and sustainable sodium-ion batteries.

The findings were recently published in the journal Advanced Functional Materials.

The team worked with tiny cone- and disc-shaped carbon materials from oil and gas industry byproducts with a pure graphitic structure. The forms allow for more efficient energy storage with larger sodium and potassium ions, which is a challenge for anodes in battery research. Sodium and potassium are more widely available and cheaper than lithium.

“For years, we’ve known that sodium and potassium are attractive alternatives to lithium,” Pulickel Ajayan, the Benjamin M. and Mary Greenwood Anderson Professor of Engineering at Rice, said in a news release. “But the challenge has always been finding carbon-based anode materials that can store these larger ions efficiently.”

Lithium-ion batteries traditionally rely on graphite as an anode material. However, traditional graphite structures cannot efficiently store sodium or potassium energy, since the atoms are too big and interactions become too complex to slide in and out of graphite’s layers. The cone and disc structures “offer curvature and spacing that welcome sodium and potassium ions without the need for chemical doping (the process of intentionally adding small amounts of specific atoms or molecules to change its properties) or other artificial modifications,” according to the study.

“This is one of the first clear demonstrations of sodium-ion intercalation in pure graphitic materials with such stability,” Atin Pramanik, first author of the study and a postdoctoral associate in Ajayan’s lab, said in the release. “It challenges the belief that pure graphite can’t work with sodium.”

In lab tests, the carbon cones and discs stored about 230 milliamp-hours of charge per gram (mAh/g) by using sodium ions. They still held 151 mAh/g even after 2,000 fast charging cycles. They also worked with potassium-ion batteries.

“We believe this discovery opens up a new design space for battery anodes,” Ajayan added in the release. “Instead of changing the chemistry, we’re changing the shape, and that’s proving to be just as interesting.”

---

This story originally appeared on EnergyCapitalHTX.com.

View All Listings